drugset / Trial / NCT06615752
Green Tea and Quercetin in Combination With Docetaxel Chemotherapy in Castration-resistant Prostate Cancer Patients
Phase 1/2
Recruiting
99 enrolled
Charles Drew University of Medicine and Science
National Institute on Minority Health and Health Disparities (NIMHD) · collabWatts Healthcare Corporation · collab
RandomizedSequentialQuadruple-blindTreatment
Summary
The goal of this clinical trial is to find out if taking natural products green tea and quercetin along with docetaxel chemotherapy improves the therapy of advanced prostate cancer, i.e., metastatic castration-resistant prostate cancer (mCRPC). It will also learn about the safety of this combination. Researchers will compare green tea plus quercetin to a placebo (a look-alike substance that contains no drug) in combination with docetaxel to see if green tea and quercetin works to improve the therapeutic effect of docetaxel.
Timeline
- Start
- 2026-10
- Primary completion
- 2028-04
- Completion
- 2029-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Quercetin | Small molecule | — | — |
| Subject | green tea extract | Unknown | — | — |
| Background | Docetaxel | Small molecule | — | — |